Shares of Nordson Corporation (NDSN) surged 5.49% in after-hours trading on Wednesday, following the release of the company's fiscal second-quarter 2025 results that exceeded analyst expectations. The dispensing equipment maker reported robust financial performance and provided an optimistic outlook, driving investor enthusiasm.

Nordson announced adjusted earnings per share of $2.42 for the quarter ended April 30, surpassing the analyst consensus estimate of $2.36. This represents a 3.42% increase from $2.34 per share in the same period last year. The company's quarterly sales reached $682.94 million, up 4.96% year-over-year and beating the analyst estimate of $674.04 million.

The strong performance was attributed to several factors, including an 8% favorable acquisition impact, which helped offset a 2% organic sales decrease. Nordson's medical and fluid solutions business, bolstered by the acquisition of Atrion in May 2024, saw a significant 20% sales growth to $203 million. The company also reported a 5% growth in backlog during the quarter, indicating potential for future revenue growth. Looking ahead, Nordson provided an optimistic third-quarter outlook, forecasting adjusted earnings per share between $2.55 and $2.75, and sales between $710 million and $750 million, both ranges surpassing current analyst expectations.